Patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration. research hub

The HIt HArd and hiT early in multiple sclerosis trial – HiHat trial

This study, called HiHat, is looking into new treatments for relapsing-remitting multiple sclerosis (MS) in people who have had the condition for less than 10 years. It's investigating if certain medicines can stop MS from getting worse, while making sure they are safe.